DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 14A

(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant 

Filed by a Party other than the Registrant 

Check the appropriate box:

5 

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material under § 240.14a-12

 

PYXIS ONCOLOGY, INC.

(Name of Registrant as Specified in its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

No fee required.

Fee paid previously with preliminary materials.

Fee computed on table in exhibit required per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

 

 


https://cdn.kscope.io/5705f33fbe5d3451cc75d9cf7bb69079-img265883665_0.jpg 

PYXIS ONCOLOGY P.O BOX 8016, CARY, NO 27512-9903 Pyxis Oncology, Inc. Important Notice Regarding the Availability of Proxy Materials Stockholders Meeting to be held on June 13, 2023. For stockholders of record as of April 20, 2023 This communication presents only an overview of the more complete proxy materials that are available to you on the internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting. To view the proxy materials, and to obtain directions to attend the meeting. go to: www.proxydocs.com/PYXS To vote your proxy while visiting this site, you will need the 12 digit control number in the box below. Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet. For a convenient way to view proxy materials and VOTE go to www.proxydocs.com/PYXS Have the 12 digit control number located in the shaded box above available when you access the website and follow the instructions. If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request on or before June 02, 2023. To order paper materials, use one of the following methods. INTERNET www.investorelections.com/PYXS TELEPHONE (866) 648-8133 When requesting via the Internet or telephone you will need the 12 digit control number located in the shaded box above. * E-MAIL paper@investorelections.com If requesting materials by email, please send a blank e-mail with the 12 digit control number (located above) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material. Meeting Type: Annual Meeting of Stockholders Date: Tuesday, June 13, 2023 Time: 10:00 AM, Eastern Time Pyxis Oncology, Inc. Place: Annual Meeting to be held live via the Internet - please visit www.proxydocs.com/PYXS for more details. You must register to attend the meeting online and/or participate at www.proxydocs.com/PYXS SEE REVERSE FOR FULL AGENDA

 


https://cdn.kscope.io/5705f33fbe5d3451cc75d9cf7bb69079-img265883665_1.jpg 

 

Pyxis Oncology, Inc. Annual Meeting of Stockholders THE BOARD OF DIRECTORS RECOMMENDS A VOTE: FOR ON PROPOSALS 1 AND 2 PROPOSAL 1. Election of Class I Director and Class II Directors 1.01 Rachel Humphrey, M.D. 1.02 Freda Lewis-Hall, M.D. 1.03 Thomas Civik 2. Ratification of the Appointment of Ernst & Young LLP as our Independent Registered Public Accounting Firm for the Fiscal Year ending December 31, 2023 NOTE: The transaction of such other business as may properly come before the meeting.